Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Moody microbes or fecal phrenology: what do we know about the microbiota-gut-brain axis?
A triple-effect cocktail produced by neural stem cells as a novel neurorepair therapy for chronic stage CNS autoimmunity.
Boosting CNS axon regeneration by circumventing limitations of natural cytokine signaling.
Cost-Utility Analysis (cua) Of First-Line Disease-Modifying Treatments (DMT) Versus Best Supportive Care (Bsc) In Finnish Relapsing-Remitting Multiple Sclerosis (RRMS) Patients.
Analysis of the Recent HTA Decision Making Landscape for Multiple Sclerosis Therapies - Trends and Future Opportunities.
A review of Neuropharmacology Effects of Nigella sativa and Its Main Component, Thymoquinone.
MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosis.
Efficacy of hematopoietic stem cell formultiple sclerosis, an evidence based meta-analysis.
Multiple sclerosis: Bigger brains resist disability in MS.
A comparison of multiple sclerosis clinical disease activity between patients treated with natalizumab and fingolimod.
Hippocampal expressions of metallothionein I/II and glycoprotein 96 in EAE-prone and EAE-resistant strains of rats.
Construct Validity of the Four Square Step Test in Multiple Sclerosis.
[The biological role of sulfatides].
The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population.
Expected Value of Partial Perfect Information for the Disability Progression Efficacy of Teriflunomide and Fingolimod in the Treatment of Relapsing-Remitting Multiple Sclerosis.
Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55.
Co-occurrence of multiple sclerosis and Parkinson disease.
Sodium intake is associated with increased disease activity in multiple sclerosis.
Caveolin-1 Is Critical for Lymphocyte Trafficking into Central Nervous System during Experimental Autoimmune Encephalomyelitis.
Analysis of Expenditure in Multiple Sclerosis Disease Modifying Therapies Evolution Between 2004-2013 in Spain.
Static posturography across the EDSS scale in people with multiple sclerosis: a cross sectional study.
All relapsing multiple sclerosis patients should be seen in specialist clinics - NO.
Evaluation of Disability Progression as an Endpoint in Clinical Trials for Relapsing-Remitting Multiple Sclerosis (RRMS): Comparison of the Define and Confirm Studies.
A surface-based technique for mapping homotopic interhemispheric connectivity: Development, characterization, and clinical application.
Gut environment-induced intraepithelial autoreactive CD4(+) T cells suppress central nervous system autoimmunity via LAG-3.

Pages